UA111333C2 - Спосіб одержання l-аргінінової солі периндроприлу - Google Patents

Спосіб одержання l-аргінінової солі периндроприлу

Info

Publication number
UA111333C2
UA111333C2 UAA201300118A UAA201300118A UA111333C2 UA 111333 C2 UA111333 C2 UA 111333C2 UA A201300118 A UAA201300118 A UA A201300118A UA A201300118 A UAA201300118 A UA A201300118A UA 111333 C2 UA111333 C2 UA 111333C2
Authority
UA
Ukraine
Prior art keywords
perindropryl
producing
arginine salt
arginine
salt
Prior art date
Application number
UAA201300118A
Other languages
English (en)
Inventor
Ліноль Жюлі
Лоран Стефан
Грен'є Арно
Матьйо Себастієн
Original Assignee
Ле Лаборатуар Сервьє
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47427278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA111333(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ле Лаборатуар Сервьє filed Critical Ле Лаборатуар Сервьє
Publication of UA111333C2 publication Critical patent/UA111333C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines

Abstract

Спосіб одержання сполуки формули (І):. (І)
UAA201300118A 2012-01-05 2013-01-03 Спосіб одержання l-аргінінової солі периндроприлу UA111333C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1200034A FR2985512B1 (fr) 2012-01-05 2012-01-05 Procede de preparation du sel de l-arginine du perindopril

Publications (1)

Publication Number Publication Date
UA111333C2 true UA111333C2 (uk) 2016-04-25

Family

ID=47427278

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201300118A UA111333C2 (uk) 2012-01-05 2013-01-03 Спосіб одержання l-аргінінової солі периндроприлу

Country Status (46)

Country Link
US (1) US8865915B2 (uk)
EP (1) EP2612851B1 (uk)
JP (1) JP5722924B2 (uk)
KR (1) KR101502946B1 (uk)
CN (1) CN103193863B (uk)
AP (1) AP2013006655A0 (uk)
AR (1) AR089632A1 (uk)
AU (1) AU2012268816B2 (uk)
BR (1) BR102013000256B1 (uk)
CA (1) CA2801089C (uk)
CL (1) CL2013000022A1 (uk)
CO (1) CO6700138A1 (uk)
CR (1) CR20120654A (uk)
CU (1) CU24293B1 (uk)
CY (1) CY1118079T1 (uk)
DK (1) DK2612851T3 (uk)
EA (1) EA022573B1 (uk)
EC (1) ECSP13012366A (uk)
ES (1) ES2595236T3 (uk)
FR (1) FR2985512B1 (uk)
GE (1) GEP20146183B (uk)
GT (1) GT201300002A (uk)
HR (1) HRP20161145T1 (uk)
HU (1) HUE030042T2 (uk)
IL (1) IL223753A (uk)
JO (1) JO3196B1 (uk)
LT (1) LT2612851T (uk)
MA (1) MA35001B1 (uk)
MD (1) MD4415C1 (uk)
ME (1) ME02493B (uk)
MX (1) MX2013000009A (uk)
MY (1) MY160902A (uk)
NI (1) NI201200195A (uk)
PE (1) PE20131098A1 (uk)
PH (1) PH12012000392B1 (uk)
PL (1) PL2612851T3 (uk)
PT (1) PT2612851T (uk)
RS (1) RS55096B1 (uk)
SA (1) SA113340172B1 (uk)
SG (1) SG192337A1 (uk)
SI (1) SI2612851T1 (uk)
TN (1) TN2012000620A1 (uk)
TW (1) TWI449693B (uk)
UA (1) UA111333C2 (uk)
UY (1) UY34553A (uk)
WO (1) WO2013102740A1 (uk)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
TWI544987B (zh) 2015-10-27 2016-08-11 財團法人工業技術研究院 輕便型動力工具
WO2019071209A1 (en) 2017-10-06 2019-04-11 Rad Steve SYSTEM AND KIT OF INCREASED REALITY
US10430658B2 (en) 2017-10-06 2019-10-01 Steve Rad Augmented reality system and kit
CN110283104B (zh) * 2018-08-22 2022-06-14 南京济群医药科技股份有限公司 一种精氨酸培哚普利的制备方法
CN112047999B (zh) * 2020-09-18 2022-12-02 天津力生制药股份有限公司 一种γ晶型的精氨酸培哚普利盐的制备方法
CN114149357A (zh) * 2021-12-29 2022-03-08 江苏嘉逸医药有限公司 一种γ晶型培哚普利精氨酸盐的制备方法
CN114894940A (zh) * 2022-06-02 2022-08-12 江苏嘉逸医药有限公司 一种高效液相色谱法测定精氨酸培哚普利中杂质的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
AR036187A1 (es) * 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
CN100472337C (zh) 2003-09-18 2009-03-25 澳大利亚研究实验室持股有限公司 提高液体静电印刷调色剂或液体喷墨油墨的物理性质和电性质的方法
US7291745B2 (en) * 2005-03-21 2007-11-06 Glenmark Pharmaceuticals Limited Process for the preparation of perindopril
FR2897865B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897866B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
EP1864973A1 (en) * 2006-06-09 2007-12-12 Sochinaz SA Process for the preparation of perindopril and salts thereof
WO2009157018A2 (en) * 2008-06-24 2009-12-30 Matrix Laboratories Ltd Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof
AU2009212902A1 (en) * 2008-09-03 2010-03-18 Apotex Pharmachem Inc. Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof
SI23001A (sl) * 2009-03-20 2010-09-30 Diagen@d@o@o Nove soli perindoprila nov postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni

Also Published As

Publication number Publication date
GEP20146183B (en) 2014-10-27
EA201201667A1 (ru) 2013-09-30
CA2801089A1 (fr) 2013-07-05
PH12012000392A1 (en) 2014-07-28
US8865915B2 (en) 2014-10-21
ME02493B (me) 2017-02-20
FR2985512A1 (fr) 2013-07-12
MA35001B1 (fr) 2014-04-03
EP2612851A1 (fr) 2013-07-10
MX2013000009A (es) 2013-07-15
PL2612851T3 (pl) 2016-12-30
MD20120129A2 (en) 2013-07-31
EP2612851B1 (fr) 2016-07-06
CU24293B1 (es) 2017-12-08
HUE030042T2 (en) 2017-04-28
JO3196B1 (ar) 2018-03-08
WO2013102740A1 (fr) 2013-07-11
JP2013139445A (ja) 2013-07-18
ES2595236T3 (es) 2016-12-28
TW201332969A (zh) 2013-08-16
PT2612851T (pt) 2016-08-01
HRP20161145T1 (hr) 2016-11-18
MD4415C1 (ro) 2016-11-30
NI201200195A (es) 2013-06-03
CR20120654A (es) 2013-09-03
PE20131098A1 (es) 2013-10-12
CN103193863A (zh) 2013-07-10
SI2612851T1 (sl) 2016-11-30
EA022573B1 (ru) 2016-01-29
SA113340172B1 (ar) 2015-07-09
KR20130080813A (ko) 2013-07-15
KR101502946B1 (ko) 2015-03-16
IL223753A (en) 2015-08-31
GT201300002A (es) 2014-06-09
RS55096B1 (sr) 2016-12-30
TWI449693B (zh) 2014-08-21
AU2012268816A1 (en) 2013-07-18
JP5722924B2 (ja) 2015-05-27
BR102013000256B1 (pt) 2020-06-02
IL223753A0 (en) 2013-07-31
MY160902A (en) 2017-03-31
AP2013006655A0 (en) 2013-01-31
SG192337A1 (en) 2013-08-30
CN103193863B (zh) 2017-03-01
UY34553A (es) 2013-07-31
CO6700138A1 (es) 2013-06-28
MD4415B1 (ro) 2016-04-30
TN2012000620A1 (fr) 2014-04-01
ECSP13012366A (es) 2014-08-29
PH12012000392B1 (en) 2014-07-28
LT2612851T (lt) 2016-09-26
FR2985512B1 (fr) 2014-06-20
CY1118079T1 (el) 2017-06-28
AU2012268816B2 (en) 2014-12-11
CL2013000022A1 (es) 2014-07-25
AR089632A1 (es) 2014-09-03
CU20130003A7 (es) 2014-08-28
US20130178635A1 (en) 2013-07-11
DK2612851T3 (en) 2016-10-03
BR102013000256A2 (pt) 2013-12-03
CA2801089C (fr) 2015-03-31

Similar Documents

Publication Publication Date Title
UY35683A (es) Polimorfo de inhibidores de tirosina quinasa de bazo (syk)
CR20140463A (es) Compuestos de heterociclilo como inhibidores de mek
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
JO3515B1 (ar) مثبطات fgfr4 بيريميدين
CR20130539A (es) Triazolopiridinas
UY34763A (es) Inhibidores de la agregación plaquetaria
UY33958A (es) Inhibidores de la glucosilceramida sintasa
UY34472A (es) Derivados modificados de 4-fenil-piridina
UA111333C2 (uk) Спосіб одержання l-аргінінової солі периндроприлу
CR20150061A (es) Compuesto de pirazolopirimidinas
UY34654A (es) Inhibidores de la beta-secretasa
UY33930A (es) Inhibidores novedosos de quinasas
EA201490474A1 (ru) Аминохиназолины в качестве ингибиторов киназ
EA201301130A1 (ru) Имидазопиридазины в качестве ингибиторов акт киназы
UY33976A (es) Derivados de pirazolo-pirimidina.
IN2014DN06192A (uk)
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
CR20150006A (es) Metodo para preparar triazolopiridinas sustituidas
EA201200123A1 (ru) Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей
CR20150028A (es) Derivados de ariletinilo
CR20140531A (es) Derivados de ariletinilo
IN2013MU04056A (uk)
EA201592221A1 (ru) Способ получения ивабрадина
MX371011B (es) Intermediarios y métodos para sintetizar derivados de calicheamicina.
EA201690593A1 (ru) Новые соединения мочевины